Statement of Accreditation Status
Geisinger Commonwealth School of Medicine
- CEO: Dr. Julie Byerley, President and Dean
- Accreditation Liaison Officer: Dr. Andrea DiMattia
- Commission Staff Liaison: Michael Sachs, Vice President
- Carnegie Classification: Special Focus: Medical Schools and Centers » No research designation
- Control: Private (Non-Profit)
- Former Name(s): Commonwealth Medical College, The (3/17/2017) Geisinger Commonwealth School of Medicine (Prior to 8/16/2022) Geisinger College of Health Sciences (prior to 9/11/2023)
- Phase: Accredited
- Status: Accreditation Reaffirmed
- Candidacy Granted: January 1, 2009
- Accreditation Granted: June 26, 2014
- Last Reaffirmation: June 27, 2019
- Next Self-Study Evaluation: 2026-2027
- June 26, 2024
To acknowledge receipt of the substantive change request. To note the institution's decision to close the additional location at 3805 Old Easton Rd, Doylestown, PA 18902 that ceased operations effective April 12, 2024. To remove the additional location from the institution's scope of accreditation. To note that the Commission reserves the right to rescind this action if any developments reveal additional information that might have affected the Commission's decision. The next evaluation visit is scheduled for 2026-2027. - April 25, 2024
To acknowledge receipt of the substantive change request. To include the relocation of the additional location from 400 Highland Ave., Lewistown, PA 17044 to 111 E. Market Street, Lewistown, PA 17044 within the institution's scope of accreditation. To require immediate notification when instruction commences at the new location and of the date that instruction ceases at the former location by email to [email protected]. To note that the Commission reserves the right to rescind this action if any developments reveal additional information that might have affected the Commission's decision and/or the requested substantive change is not implemented within one calendar year from the date of this action. The next evaluation visit is scheduled for 2026-2027. - March 18, 2024
To note the substantive change site visit occurred on January 31, 2024, to the additional location at 400 Highland Avenue, Lewistown, PA 17044, and the information provided in the substantive change request was verified. To acknowledge receipt of documentation of approval from the United States Department of Education. The next evaluation visit is scheduled for 2026-2027. - March 14, 2024
To acknowledge receipt of the supplemental information report requested by the Commission action of October 30, 2023. The next evaluation visit is scheduled for 2026-2027. - October 30, 2023
Staff acted on behalf of the Commission to request a supplemental information report, due November 15, 2023, that provides additional information on Standard II: Ethics and Integrity; Standard III: Design and Delivery of the Student Learning Experience; Standard IV: Support of the Student Experience; and Standard VI: Planning, Resources, and Institutional Improvement. The next evaluation visit is scheduled for 2026-2027. - August 24, 2023
To acknowledge receipt of the substantive change request. To include the relocation of the additional location at 426 Maple Ave., Lewistown, PA 17044 to 400 Highland Ave., Lewistown, PA 17044 within the institution's scope of accreditation. To require written evidence of approvals from all necessary licensing, regulatory, or other legal entities as necessary including the United States Department of Education. To note that the Commission may rescind this action if the requested substantive change is not implemented within one calendar year from the date of this action. The next evaluation visit is scheduled for 2026-2027. - February 21, 2023
To acknowledge receipt of the substantive change request. To include the additional location at 426 Maple Ave, Lewistown, PA 17044 within the institution's scope of accreditation. To require immediate notification when instruction commences at the additional location. To direct a substantive change site visit as soon as practicable but no later than six months after the commencement of instruction at the additional location. To require written evidence of approvals from all necessary licensing, regulatory, or other legal entities as necessary, including the United States Department of Education. To note that the Commission may rescind this action if instruction does not commence within one calendar year from the date of this action. The next evaluation visit is scheduled for 2026-2027. - April 16, 2020
To acknowledge receipt of formal written notice from the institution in response to the Commission's request of March 9, 2020. To temporarily waive Substantive Change Policy and Procedures and allow the use of distance education to accommodate students impacted by coronavirus (COVID-19) interruptions, in accordance with United States Department of Education (USDE) guidelines published March 5, 2020. Continued use of distance education beyond the limitations of USDE guidelines will require substantive change approval in accordance with Substantive Change Policy and Procedures. This flexibility is not available for clock-hour courses that lead to licensure if the licensing body will not accept distance learning courses or hours or give credit for them toward the number of hours a student must complete. The next evaluation visit is scheduled for 2026-2027. - June 27, 2019
To acknowledge receipt of the self-study report. To note the visit by the Commission's representatives. To reaffirm accreditation. The next evaluation visit is scheduled for 2026-2027. - April 30, 2019
To acknowledge receipt of the substantive change request. To include the first alternative delivery method-distance education program (Master of Biomedical Science program) within the scope of accreditation. To note that the Commission may rescind this action if the requested substantive change is not implemented within one calendar year from the date of this action. To note that the evaluation visit has occurred and will be acted upon by the Commission in the June meeting.
- Distance Education
Approved to offer programs by this delivery method - Correspondence Education
Not approved for this delivery method
Approved Credential Levels
The following represents credential levels included in the scope of the institution’s accreditation:
- Associate's Degree or Equivalent Included within the scope to offer ONE program: Associates Degree in Nursing
- Master's Degree or Equivalent Included within the scope
- Doctor's Degree - Professional Practice Included within the scope
- Main Campus
Geisinger Commonwealth School of Medicine
525 Pine Street
Scranton, PA 18509 - Additional Location
Geisinger College of Health Sciences, School of Nursing
111 E. Market Street
Lewistown, PA 17044
Opened: 05/06/2024 - Other Instructional Site
AtlantiCare Regional Medical Center
1925 Pacific Avenue
Atlantic City, NJ 08401 - Other Instructional Site
Danville Regional Campus
Geisinger Medical Center, 100 North Academy Avenue
Danville, PA 17822 - Other Instructional Site
Geisinger South Wilkes-Barre
25 Church Street, Fourth Floor
Wilkes-Barre, PA 18764 - Other Instructional Site
Guthrie Regional Campus
1 Guthrie Square
Sayre, PA 18840 - Other Instructional Site
West Regional Campus (Lewistown/State College)
400 Highland Ave
Lewistown, PA 17044
The following are links to sites that are not maintained by the MSCHE. These are provided as additional external resources about each institution that the MSCHE accredits.
